findmyKOL
Clinical trialNCT07661498Not, yet, recruitingPhase 4Interventional

Indomethacin for Biliary ERCP Patients

SponsorUniversity of California, San FranciscoEnrollment860PancreatitisPancreatitis Acute BiliaryPancreatitis BiliaryPost-ERCP Acute PancreatitisPost-ERCP Adverse EventsPost-ERCP Pancreatitis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of California, San Francisco

    San Francisco, California, United States

    Abdul Kouanda, MDMichael C Larsen, MDPatrick Avila, MD, MPHSun-Chuan Dai, MD

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jul 2026
Primary completion
31 Jul 2031
Completion
31 Jul 2031
Last update posted
22 Jun 2026
Registered enrollment
860
Registry id
NCT07661498
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.